Siga Technologies Inc (SIGA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Siga Technologies Inc  (NASDAQ: SIGA)

Siga Technologies Inc

Officers & Directors


Executives:

- Diem Nguyen, Ph.D., Chief Executive Officer
- Daniel J. Luckshire, Executive Vice President

Directors:

- Jaymie Durnan
- Jay K. Varma
- Joseph Marshall
- Harold E. Ford, Jr.
- Gary J. Nabel
- Julian Nemirovsky
- Holly L. Phillips
- Evan Knisely ,

Siga Technologies Inc currently has 49 employees.

  News about Siga Technologies Inc Key Personnel

TEPOXX Takes Center Stage: A New Dawn in the Fight Against Orthopoxviruses,

Expansion of TEPOXX (Tecovirimat) Approval Signals Hope Against Orthopoxvirus ThreatsIn a landmark decision, SIGA Technologies has announced that its antiviral treatment, TEPOXX (tecovirimat), has been officially approved in Japan for addressing a range of orthopoxvirus infections. This announcement, made on January 2, 2025, confirms TEPOXX as a significant therapeutic option for smallpox, mpox (formerly known as monkeypox), and cowpox, as well as for managing complications arising from smallpox vaccination. Regulatory Approval and Its SignificanceThe approval by Japan s Pharmaceuticals and Medical Devices Agency (PMDA), in conjunction with the Ministry of Health, Labour and Welfare, marks TEPOXX as the f...

SIGA Technologies' Appoints Larry Miller as General Counsel, Ushering in a New Era of Legal Excellence in Pursuit of Health Security

Introducing Larry Miller: SIGA Technologies Latest Addition Bolsters Legal Team in Pursuit of Health Security Excellence
: March 25, 2024
Publication:
In the ever-evolving landscape of health security and infectious diseases, SIGA Technologies, Inc. (NASDAQ: SIGA), a leading commercial-stage pharmaceutical company, solidifies its commitment to excellence with the appointment of Larry Miller as its general counsel. Effective immediately, Miller brings a wealth of legal expertise and diverse industry experience to fortify SIGA s legal team, propelling the company to new heights in its pursuit of safeguarding global health.
SIGA Technologies has long been renowned for its cutting-edge researc...

SIGA Technologies Appoints Dr. Diem Nguyen as New CEO Amidst Financial Challenges



SIGA Technologies, Inc. (SIGA), a prominent pharmaceutical company specializing in the health security market, has recently shared news of the appointment of Dr. Diem Nguyen as their new Chief Executive Officer (CEO). With expertise encompassing a Ph.D. and an MBA, Dr. Nguyen s arrival is anticipated to bring fresh perspective and drive growth for SIGA starting January 27, 2024. Concurrently, the current CEO, Dr. Phil Gomez, will step down from his position the day before, marking the beginning of a new era for the company.
Financial Performance Overview:
Despite the forthcoming leadership transition, SIGA Technologies faces a significant challenge with its financial performance. In the twe...






SIGA Management Effectiveness SIGA Revenue per Employee SIGA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.